A practical approach on radioprotection in the treatment of radioiodine for thyroid cancer
DOI:
https://doi.org/10.15392/bjrs.v6i3.557Keywords:
medical physics, radioiodine, radioprotectionAbstract
There are several protocols for the treatment and follow-up of differentiated thyroid cancer. All of them gather evidence on the evolution and treatment and try to establish a treatment standard. However, there are few occasions in which this issue is addressed from the standpoint of radiological protection, as the ICRP 94 and TECDOC 1608. The focus of our work is to demonstrate that simple actions in the routine of workers in the Nuclear Medicine Service interfere positively in the radiation protection of all those involved in the patient's care, also optimizing their well being during the procedure. In the current model, the patient participates in an interview with nurses, doctors and physicists, before admission, and receives written and verbal information about the treatment procedures in order to diminish his anxiety and clarify possible doubts. In all the cases under hospital care there were no instances of high exposure (above 1mSv/month or 6 mSv/year) among the staff. With the participation of all involved, there was an escalating improvement in the reduction of complications generated by the patient’s anxiety, waste decrease, providing better comfort during hospital care) and minimization of occupational hazard affecting the staff in charge of the patient’s room maintenance after hospital leave.
- Views: 117
- PDF Downloads: 130
Downloads
References
INCA - Instituto Nacional de Câncer - Estimativa 2018 - Síntese de Resultados e Comentários. Available at: <http://www.inca.gov.br/estimativa/2018/sintese-de-resultados-comentarios.asp>. Accessed in: 18 maio. 2018.
SCHLUMBERGER; FILETTI; HAY. Nontoxic goiter and thyroid neoplasia. In: MELMED, S. et al. (Eds.). Williams textbook of endocrinology. 13th edition ed. Philadelphia, PA: Elsevier, 2016. p. 457–490.
MACIEL, R. M. B.; BISCOLLA, R. P. M.. Diagnóstico e tratamento do câncer de tiróide. In: Vilar L (editor). Endocrinologia Clinica. 3ª ed. Rio de Janeiro: Medsi, 2006. p. 240-52.
SHERMAN, S.. Thyroid carcinoma. Lancet, 2003. 361:501-11.
SEIDLIN, S.M., MARRINELLI, L.D., OSHRY, E.. Radioactive iodine therapy: Effect on functioning metastases of adenocarcinoma of thyroid, JAMA 132 (1946) p. 838-847.
INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTION; INTERNATIONAL ATOMIC ENERGY AGENCY. Release of patients after radionuclide therapy. Vienna, Austria: International Atomic Energy Agency, 2009.
PRYMA, D. A.; MANDEL, S. J. Radioiodine Therapy for Thyroid Cancer in the Era of Risk Stratification and Alternative Targeted Therapies. Journal of Nuclear Medicine, v. 55, n. 9, p. 1485–1491, 1 set. 2014.
Haugen, B, R. et al.2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, v26, n.1 Special Article, 2016.
PACINI, F.; SCHLUMBERGER, M.; DRALLE, H.; ELISEI, R.; SMIT, JWA.; WIERSINGA, W. M. and the EUROPEAN THYROID CANCER TASKFORCE. Consensus Statement. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol, 2006. 154:787-803.
INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTION (ICRP). Release of Patients after Therapy with Unsealed Radionuclides. ICRP Publication 94. Ann. ICRP 34 (2). 2004
INTERNATIONAL ATOMIC ENERGY AGENCY (IAEA). Nuclear Medicine in Thyroid Cancer Management: A Practical Approach. IAEA Tecdoc Series No. 1608. 2009b.
MOREIRA, M. A.; MASINI, E. F. S.; Aprendizagem significativa a teoria de David Ausubel. Ed.Moraes LTDA: São Paulo, 1992.
COMISSÃO NACIONAL DE ENERGIA NUCLEAR (CNEN). NN 3.01. Resolução 164/14, Diretrizes básicas de radioproteção. Rio de Janeiro, RJ: CNEN, 2014.
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Brazilian Journal of Radiation Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing: The BJRS articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/